4 completed, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 4, Unknown 1 |
Follow Advanced Prostate Cancer: new trials by email Literature Review of Advanced Prostate Cancer trials Research Report on Advanced Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer DKF-MA102 - Advanced Prostate Cancer | Phase 3 | Completed | Dongkook Pharmaceutical Co., Ltd. | 161 | 2024-05-30 | 2026-08-14 |
| Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate Triptorelin pamoate (embonate) salt - Advanced Prostate Cancer, Metastatic Prostate Cancer | Phase 3 | Completed | Ipsen | 195 | 2022-11-17 | 2025-09-09 |
| The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. Leuprolide Injectable Emulsion (CAMCEVI®) - Advanced Prostate Cancer | Phase 3 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 137 | 2022-07-12 | 2025-05-22 |
| Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer Inj. Goserelin (Test) Subcutaneously, Inj. Zoladex (Reference) Subcutaneously - Advanced Prostate Cancer | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 94 | 2020-09-30 | 2025-04-17 |
| Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy Docetaxel + LH-RH analogues, Docetaxel, Continuous Docetaxel - Advanced Prostate Cancer | Phase 3 | Unknown | University of Turin, Italy | 600 | 2010-04-01 | 2010-10-20 |
Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Male Urogenital Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Docetaxel (1) · Goserelin (1) · Leuprolide (1) · Salts (1) · Triptorelin Pamoate (1)
Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Dongkook Pharmaceutical Co., Ltd. (1) · Eurofarma Laboratorios S.A. (1) · Ipsen (1) · University of Turin, Italy (1)
China (2) · India (1) · Italy (1) · South Korea (1)
Alfredo Berruti, PHD (1) · Bruno Castagneto, MD (1) · Bumjin Lim, M.D. (1) · Cheol Kwak, M.D.,Ph.D (1) · Choung-Soo Kim, M.D.,Ph.D (1) · Jae Young Joung, M.D.,Ph.D (1) · Ji Youl Lee, M.D.,Ph.D (1) · Kyo Chul Koo, M.D.,Ph.D (1) · Marcello Tucci, MD (1) · Seong Soo Jeon, M.D.,Ph.D (1) · Sung Kyu Hong, M.D.,Ph.D (1)